Extracellular vesicles in cerebrospinal fluid as possible biomarkers for multiple sclerosis

被引：0
|
作者：
Salemi, G.
Ragonese, P.
Geraci, F. [1 ]
Allotta, E. [1 ]
Barreca, M. M. [1 ]
Realmuto, S.
Mazzola, M. A. [2 ]
Sconzo, G. [1 ]
Savettieri, G.
机构：
[1] Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol STEBICE, Palermo, Italy
[2] Univ Palermo, Dept Expt Biomed & Clin Neurosci, Palermo, Italy
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2017年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP3110
引用
收藏
页码：407 / 407
页数：1
相关论文
共 50 条
  • [41] Cerebrospinal fluid profiles in clinically isolated syndromes and possible multiple sclerosis
    Laroni, A.
    Ranzato, F.
    Rinaldi, L.
    Perini, P.
    Battistin, L.
    Gallo, P.
    [J]. MULTIPLE SCLEROSIS, 2007, 13 : S110 - S110
  • [42] Are total blood-derived extracellular vesicles specific biomarkers of multiple sclerosis?
    TorresIglesias, G.
    Gutierrez-Fernandez, M.
    Fernandez-Fournier, M.
    Munoz, I. Puertas
    Laso-Garcia, F.
    Montero-Calle, A.
    Chamorro, B.
    Miranda-Carus, M.
    Diez-Tejedor, E.
    Otero-Ortega, L.
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2022, 42 (1_SUPPL): : 148 - 148
  • [43] CNS endothelial derived extracellular vesicles are biomarkers of active disease in multiple sclerosis
    Michael Mazzucco
    William Mannheim
    Samantha V. Shetty
    Jennifer R. Linden
    [J]. Fluids and Barriers of the CNS, 19
  • [44] Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis
    Novakova, Lenka
    Axelsson, Markus
    Khademi, Mohsen
    Zetterberg, Henrik
    Blennow, Kaj
    Malmestrom, Clas
    Piehl, Fredrik
    Olsson, Tomas
    Lycke, Jan
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 62 - 71
  • [45] Aptamer-based screening of cerebrospinal fluid for protein biomarkers of multiple sclerosis
    Soomro, Sanam
    Hughes, Samuel
    Greenberg, Benjamin
    Hanly, John
    Mohan, Chandra
    [J]. JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [46] Development of robust targeted proteomics assays for cerebrospinal fluid biomarkers in multiple sclerosis
    Astrid Guldbrandsen
    Ragnhild Reehorst Lereim
    Mari Jacobsen
    Hilde Garberg
    Ann Cathrine Kroksveen
    Harald Barsnes
    Frode S. Berven
    [J]. Clinical Proteomics, 2020, 17
  • [47] Identification of Biomarkers in Cerebrospinal Fluid and Serum of Multiple Sclerosis Patients by Immunoproteomics Approach
    Colomba, Paolo
    Fontana, Simona
    Salemi, Giuseppe
    Barranca, Marilisa
    Lo Sicco, Claudia
    Mazzola, Maria Antonietta
    Ragonese, Paolo
    Savettieri, Giovanni
    De Leo, Giacomo
    Alessandro, Riccardo
    Duro, Giovanni
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (12): : 23269 - 23282
  • [48] Proteomics-Based Technologies in the Discovery of Biomarkers for Multiple Sclerosis in the Cerebrospinal Fluid
    Lourenco, A. S. T.
    Baldeiras, I.
    Graos, M.
    Duarte, C. B.
    [J]. CURRENT MOLECULAR MEDICINE, 2011, 11 (04) : 326 - 349
  • [49] An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis
    Pieragostino, Damiana
    D'Alessandro, Michele
    di Ioia, Maria
    Rossi, Claudia
    Zucchelli, Mirco
    Urbani, Andrea
    Di Ilio, Carmine
    Lugaresi, Alessandra
    Sacchetta, Paolo
    Del Boccio, Piero
    [J]. MOLECULAR BIOSYSTEMS, 2015, 11 (06) : 1563 - 1572
  • [50] Development of robust targeted proteomics assays for cerebrospinal fluid biomarkers in multiple sclerosis
    Guldbrandsen, Astrid
    Lereim, Ragnhild Reehorst
    Jacobsen, Mari
    Garberg, Hilde
    Kroksveen, Ann Cathrine
    Barsnes, Harald
    Berven, Frode S.
    [J]. CLINICAL PROTEOMICS, 2020, 17 (01)
12345